• Return to Headlines

Esperion Therape Has Returned 37.3% Since SmarTrend Recommendation (ESPR)

By Amy Schwartz

SmarTrend identified an Uptrend for Esperion Therape (NASDAQ:ESPR) on November 18th, 2019 at $42.85. In approximately 2 months, Esperion Therape has returned 37.30% as of today's recent price of $58.83.

In the past 52 weeks, shares of Esperion Therape have traded between a low of $33.13 and a high of $61.93 and are now at $58.83, which is 78% above that low price. The 200-day and 50-day moving averages have moved 0.56% higher and 2.15% higher over the past week, respectively.

Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Esperion Therape shares.

Log in and add Esperion Therape (ESPR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights esperion therape

Ticker(s): ESPR